Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maysa Hamade

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|June 10, 2022
Current and Future Biomarkers in Multiple SclerosisJennifer Yang, Maysa Hamade, Qi Wu, et al.
The Lancet. Neurology|October 18, 2024
Comparative effectiveness of cognitive behavioural therapy, modafinil, and their combination for treating fatigue in multiple sclerosis (COMBO-MS): a randomised, statistician-blinded, parallel-arm trialTiffany J Braley, Dawn M Ehde, Kevin N Alschuler, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|June 10, 2022
Current and Future Biomarkers in Multiple SclerosisJennifer Yang, Maysa Hamade, Qi Wu, et al.
The Lancet. Neurology|October 18, 2024
Comparative effectiveness of cognitive behavioural therapy, modafinil, and their combination for treating fatigue in multiple sclerosis (COMBO-MS): a randomised, statistician-blinded, parallel-arm trialTiffany J Braley, Dawn M Ehde, Kevin N Alschuler, et al.
Pageof 1